Submission Details
| 510(k) Number | K103693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 17, 2010 |
| Decision Date | February 15, 2011 |
| Days to Decision | 60 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K103693 is an FDA 510(k) clearance for the VANTAGE ABI, a System, Measurement, Blood-pressure, Non-invasive (Class II — Special Controls, product code DXN), submitted by Summit Doppler Systems, Inc. (Golden, US). The FDA issued a Cleared decision on February 15, 2011, 60 days after receiving the submission on December 17, 2010. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1130.
| 510(k) Number | K103693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 17, 2010 |
| Decision Date | February 15, 2011 |
| Days to Decision | 60 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXN — System, Measurement, Blood-pressure, Non-invasive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1130 |